NCT05807035View on ClinicalTrials.gov

Autologous Tumour Vaccine Trial

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 10, 2023

Primary Completion Date

February 10, 2026

Study Completion Date

February 10, 2028

Conditions
Solid Tumor
Interventions
BIOLOGICAL

Radvax

Vaccine extracted from patient's own tumour tissue formulated with polysaccharide adjuvant

Trial Locations (1)

5046

RECRUITING

ARASMI, Adelaide

All Listed Sponsors
collaborator

Australian Respiratory and Sleep Medicine Institute

OTHER

lead

Vaxine Pty Ltd

INDUSTRY